Veronica Conca Selected Research

Veronica Conca Research Topics

22	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 01/2021
7	Neoplasms (Cancer) 11/2023 - 01/2022
4	Neoplasm Metastasis (Metastasis) 06/2023 - 01/2022
4	Disease Progression 01/2023 - 01/2021
4	Microsatellite Instability 10/2022 - 01/2021
2	Rectal Neoplasms (Rectal Cancer) 01/2023 - 09/2022
2	Neutropenia 01/2023 - 01/2022
1	Triple Negative Breast Neoplasms 01/2023
1	Neoplasm Micrometastasis 01/2023
1	Residual Neoplasm 11/2022
1	Hypertension (High Blood Pressure) 02/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022
1	Febrile Neutropenia 01/2022
1	Ascites 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Obesity 01/2022
1	Myocardial Infarction 01/2022

10	Bevacizumab (Avastin)FDA Link 11/2023 - 01/2021
7	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
4	regorafenibIBA 10/2023 - 12/2021
4	Irinotecan (Camptosar)FDA LinkGeneric 06/2023 - 01/2022
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2023 - 01/2022
3	atezolizumabIBA 01/2023 - 01/2022
3	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2022
2	trifluridine tipiracil drug combinationIBA 10/2023 - 01/2022
2	Circulating Tumor DNAIBA 01/2023 - 11/2022
2	Panitumumab (Vectibix)FDA Link 01/2022 - 12/2021
2	Leucovorin (Folinic Acid)FDA Link 01/2022 - 01/2022
1	Messenger RNA (mRNA)IBA 10/2023
1	Monoclonal AntibodiesIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Trinitrotoluene (TNT)IBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	Angiopoietin-2IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	SaltsIBA 01/2022
1	Calcibiotic Root Canal SealerIBA 01/2022
1	PlatinumIBA 01/2022

7	Drug Therapy (Chemotherapy) 11/2023 - 01/2022
6	Therapeutics 11/2023 - 01/2021
2	Adjuvant Chemotherapy 06/2023 - 01/2023
2	Consolidation Chemotherapy 01/2023 - 09/2022
2	Neoadjuvant Therapy 01/2023 - 09/2022
2	Radiotherapy 01/2023 - 09/2022
2	Immunotherapy 10/2022 - 09/2022
1	Retreatment 01/2023